CoChat

Prostaglandin D 2 receptor antagonists in allergic disorders: safety, efficacy, and future perspectives

The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.

Abstract

Introduction: Prostaglandin D2 (PGD2) is a major cyclooxygenase mediator that is synthesized by activated human mast cells and other immune cells. The biological effects of PGD2 are mediated by D-prostanoid (DP1), DP2 (CRTH2) and thromboxane prostanoid (TP) receptors that are expressed on several immune and non-immune cells involved in allergic inflammation. PGD2 exerts various proinflammatory effects relevant to the pathophysiology of allergic disorders. Several selective, orally active, DP2 receptor antagonists and a small number of DP1 receptor antagonists are being developed for the treatment of allergic disorders.Areas covered: The role of DP2 and DP1 receptor antagonists in the treatment of asthma and allergic rhinitis.Expert opinion: Head-to-head studies that compare DP1 antagonists with the standard treatment for allergic rhinitis are necessary to verify the role of these novel drugs as mono- or combination therapies. Further clinical trials are necessary to verify whether DP2 antagonists as monotherapies or, more likely, as add-on therapies, will be effective for the treatment of different phenotypes of adult and childhood asthma. Long-term studies are necessary to evaluate the safety of targeted anti-PGD2 treatments.

Overview

Integrity signals

Registry

Crossref · 10.1080/13543784.2019.1555237

Cites

153 of 153 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 153 references

Research works printed but not linked: 8

  1. Fuller RW, 1986, Am Rev Respir Dis, 133, 252
  2. Schulman ES, 1981, Am Rev Respir Dis, 124, 402
  3. Small P, 1994, Ann Allergy, 73, 252
  4. Singh D, 2017, Clin Pharmacol, 9, 165
  5. Fitzgerald MF, 2013, Am J Respir Crit Care Med, 187, A2617
  6. Fitzgerald M, 2013, ATS Conference Proceedings, Pennsylvania, A3874
  7. Bell S, 2012, Am J Respir Crit Care Med, 185, A2756
  8. Petsky HL, 2017, Cochrane Database Syst Rev, 8, CD005603

Cited by

See all 63

Metadata

Authors
Marone, G., Galdiero, M. R., Pecoraro, A., Pucino, V., Criscuolo, G., Triassi, M., & Varricchi, G.
Affiliations
  • Ospedale Monaldi (IT)
  • University of Naples Federico II (IT)
  • Queen Mary University of London (GB)
Corresponding author
Varricchi, Gilda
Venue
Expert Opinion on Investigational Drugs
Published
2018-12-07
Volume
28
Issue
1
Pages
73-84
ISSN
  • 1354-3784 (ISSN-L)
  • 1744-7658
OpenAlex
W2902819785
Cited by
62
References
153
Citations by year
2026: 3 · 2025: 4 · 2024: 5 · 2023: 4 · 2022: 12 · 2021: 15 · 2020: 9 · 2019: 10
FWCI
5.87
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Opinion on Investigational Drugs (publishedVersion)
  • PubMed (publishedVersion)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
Funders
Regione Campania CISI-Lab Project, CRèME Projec, and TIMING Project
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
  • Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
  • Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
Keywords
prostaglandin D2, CRTH2, allergic rhinitis, asthma, allergic inflammation, mast cells, drug safety, drug efficacy
MeSH terms
Adult, Animals, Asthma, Child, Humans, Mast Cells, Receptors, Immunologic, Receptors, Prostaglandin, Drug Design, Prostaglandin D2, Anti-Allergic Agents, Rhinitis, Allergic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prostaglandin D 2 receptor antagonists in allergic disorders: safety, efficacy, and future perspectives. https://app.cochat.ai/papers/10.1080/13543784.2019.1555237
The paper
Marone, G., Galdiero, M. R., Pecoraro, A., Pucino, V., Criscuolo, G., Triassi, M., & Varricchi, G. (2019). Prostaglandin D 2 receptor antagonists in allergic disorders: safety, efficacy, and future perspectives. Expert Opinion on Investigational Drugs. https://doi.org/10.1080/13543784.2019.1555237

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.